Rockwell Medical (RMTI) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 125%. A quarter ago, it was expected that this maker of products used in the treatment of kidney disease and anemia would post a loss of $0.05 per share when it actually produced a loss of $0.02, delivering ...